Goldlan Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
as on 23-01-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.80 M
as on 23-01-2024
About Goldlan Pharmaceuticals Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2022 (FY 2021-2022). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
- CIN/LLPIN/FCRN
AAJ-9008
- Incorporation Date
05 Jul 2017
- Date of Accounts and Solvency Statement
31 Mar 2022
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Goldlan Pharmaceuticals Llp offer?
Goldlan Pharmaceuticals Llp offers a wide range of products and services, including Industrial Chemicals & Supplies, Disinfectant Chemicals, Cosmetics, Hair & Beauty Products, Body Care Products, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Cleaning Liquids & Wipes, Disinfectant Spray, Petroleum and Petrochemical Products, Solid Paraffin Wax.
Who are the key members and board of directors at Goldlan Pharmaceuticals Llp?
Designated Partners(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradyumn Rangacharya  | Designated Partner | 05-Jul-2017 | Current |
| Madhavi Jadhav | Designated Partner | 05-Jul-2017 | Current |
Financial Performance of Goldlan Pharmaceuticals Llp.
Enhance accessibility to Goldlan Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Goldlan Pharmaceuticals Llp?
Unlock access to Goldlan Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rangacharya Industries Private LimitedActive 9 years 2 monthsMadhavi Jadhav and Pradyumn Rangacharya are mutual person
- Geometric Engineers Design Private LimitedActive 3 years 17 days
Madhavi Jadhav and Pradyumn Rangacharya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Aug 2021 | ₹1.80 M | Open |
How Many Employees Work at Goldlan Pharmaceuticals Llp?
Unlock and access historical data on people associated with Goldlan Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goldlan Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goldlan Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
